• A newborn with seizures born to a mother diagnosed with primary carnitine deficiency
• A novel mutation in GLUD1 causing hyperinsulinism-hyperammonemia in a patient with high density of homozygosity on microarray: a case report
• A possible primidone embryopathy
• A randomized controlled trial of phenobarbital in neonates with hypoxic ischemic encephalopathy
• A study of the teratogenic and fetotoxic effects of large doses of barbital, hexobarbital and butobarbital used for suicide attempts by pregnant women
• Adequacy of antenatal phenobarbital dosing for neonatal intraventricular hemorrhage prophylaxis
• Advances in neonatology: vitamin K, intracranial hemorrhage, arterial pressure, hemolytic disease
• Alcohol, other drugs and the fetus
• An aborted human fetus with truncus arteriosus communis--possible teratogenic effect of Tedral
• Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn
• Antenatal phenobarbital in preventing intraventricular hemorrhage in premature newborns
• Antenatal phenobarbital therapy and neonatal outcome. I: Effect on intracranial hemorrhage
• Anti-epileptic agents during pregnancy. A prospective study on the course of pregnancy, malformations and child development
• Anticonvulsant drugs in monotherapy. Effect on the fetus
• Antiepileptic drug pharmacokinetics during pregnancy and lactation
• Calcium-stimulated adenylyl cyclases modulate ethanol-induced neurodegeneration in the neonatal brain
• Combined hypothyroidism and hypoparathyroidism in an infant after maternal 131I administration
• Comparison of the transplacental effect of luminal and epileptic seizures in pregnant rabbits on the development of the fetal nervous system
• Congenital abnormalities of 88 children born to mothers who attempted suicide with phenobarbital during pregnany: the use of a disaster epidemiological model for the evaluation of drug teratogenicity
• Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy
• Developmental effects of antiepileptic drugs and the need for improved regulations
• Diagnosis and therapy of intrahepatic cholestasis of pregnancy
• Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry
• Drug abuse in pregnancy: fetal ad neonatal effects
• Effect of drugs on intrauterine growth
• Effect of phenobarbital on the mechanism of newborn rabbit adaptation to hypoxia
• Effectiveness of a new Soviet drug Benzonal, inductor of microsomal enzymes of the liver, in the complex treatment of hemolytic disease of newborn
• Effects of prenatal ethanol exposure on later sensitivity to the low-dose stimulant actions of ethanol in mouse offspring: possible role of catecholamines
• Efficacy and failure of phenobarbital in the prevention of febrile convulsions. Importance of familial antecedents
• Exogenous hormones and other drug exposures of children with congenital heart disease
• Fetal anticonvulsant syndrome in rats: effects on postnatal behavior and brain amino acid content
• Fetal barbiturate effects
• Fetal growth in the offspring of epileptic women: results of an Italian multicentric cohort study
• Fetal onset ventriculomegaly and subependymal cysts in a pyridoxine dependent epilepsy patient
• Fetal pharmacotherapy
• Findings in newborn infants following drug abuse or drug weaning in the mother
• Goldenhar syndrome, anterior encephalocele, and aqueductal stenosis following fetal primidone exposure
• Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c)
• Hyperlipoproteinemia in newborn infants. A study of 1025 families
• Hypoplasia of the nails and end phalanges as a sequela of prenatal barbiturate exposure
• Hypoxic ischemic encephalopathy (asphyxia)
• Identification of HBV infection-associated genes in first trimester human fetal hepatocytes with suppression subtractive hybridization
• Indications for early exchange transfusion in patients with erythroblastosis fetalis
• Individualizing phenobarbital dosing in neonates
• Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction
• Interventions for perinatal hypoxic-ischemic encephalopathy
• Intrauterine intracranial hemorrhage in an infant with isoimmune thrombocytopenia
• Investigation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone for in vivo and iIn vitro murine embryopathy and embryonic ras mutations
• Jaundice in early infancy
• Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents
• Low risk of seizure recurrence after early withdrawal of antiepileptic treatment in the neonatal period
• Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes
• Maternal toxicity of drugs and metabolic disorders--a possible etiologic factor in the intrauterine death and congenital malformation: a critique on human data
• Maternal use of prescribed drugs associated with recognized fetal adverse drug reactions
• Mechanisms of asphyxial brain damage, and possible pharmacologic interventions, in the fetus
• Meta-analysis of phenobarbital usage for prevention of intraventricular hemorrhage in premature infants: factors related to variation in outcome
• Modern aspects of antiepileptic therapy during pregnancy
• Neonatal Basedow's disease in twins from a mother with severe T3 hyperthyroidism
• Neonatal effects of maternal clomipramine treatment
• Neonatal hypocalcaemia after intrauterine exposure to anticonvulsant drugs
• Neonatal manifestations of maternal phencyclidine (PCP) abuse
• Neonatal methadone withdrawal. Effect of two treatment regimens
• Neural grafting as a tool for the study and reversal of neurobehavioral birth defects
• Newborn infants of drug-addicted mothers. Review of the literature and report of personal cases
• Observations of intrauterine fetal breathing movements--a review
• Pathochemical principles of therapy in hemolytic disease of the newborn
• Pediatric aspects of success and failure of anti-D-prophylaxis
• Perinatal outcome of infants exposed to cocaine and/or heroin in utero
• Persistent neonatal hyperbilirubinemia resulting from Gilbert's syndrome in association with RhD hemolytic disease
• Pharmacokinetic basis for antenatal dosing of phenobarbital for the prevention of neonatal intracerebral hemorrhage
• Pharmacokinetics of furosemide in neonates
• Phenobarbitone in Rh hemolytic disease of the newborn: a randomized double-blinded placebo-controlled trial
• Poor neonatal adaptation following in-utero exposure to quetiapine and lamotrigine
• Post-resuscitation strategies to avoid ongoing injury following intrapartum hypoxia-ischemia
• Prenatal diagnosis of a craniopharyngioma using ultrasonography and magnetic resonance imaging
• Prenatal diagnosis of fetal seizure: a case report
• Prenatal diagnosis of intracranial teratoma. Prolonged survival after resection of a malignant teratoma diagnosed prenatally by ultrasound: a case report and literature review
• Prenatal prevention of hyperbilirubinemia due to G6PD deficiency
• Preparing the fetus for preterm birth
• Prevention of intraventricular hemorrhage in the premature infant
• Prevention of intraventricular hemorrhage in very low birth weight infants by maternally administered phenobarbital
• Psychiatric and nervous disorders
• Rhesus haemolytic disease of the newborn: Postnatal management, associated morbidity and long-term outcome
• Serum levels of phenobarbital in the newborn infant using different doses calculated for obtaining a predetermined level
• Short-Term Effects of Phenobarbitone on Electrographic Seizures in Neonates
• Susceptibility change to HBV in primary culture of first trimester human fetal hepatocytes
• Teratogenicity of anticonvulsant drugs (author's transl)
• Teratogenicity of antiepileptic drugs
• The effect of maternal narcotic addiction on the newborn infant
• The fetal primidone syndrome
• The newborn infant of the drug-dependent mother. Review of literature and personal case reports
• The teratogenicity of anticonvulsant drugs
• Theophylline reassessed
• Therapies administered to mothers at risk for preterm birth and neurodevelopmental outcome in their infants
• Uncontrolled retrospective study of 75 pregnancies in women treated for epilepsy
• Unusual association of SCN2A epileptic encephalopathy with severe cortical dysplasia detected by prenatal MRI
• Urinary excretion of phenobarbital in a neonate having withdrawal symptoms
• Use of phenobarbital, adenosine triphosphate and hemodesis in the treatment of hemolytic disease of newborn
• Variable patterns in anticonvulsant drug-induced malformations in mice: comparisons of phenytoin and phenobarbital
• Vestibular dysfunction in a child with embryonic exposure to accutane